EBANGA
Live / Registered — Registered (as of 21 Apr 2026)
What this means for you
Registered since 21 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 98599610
- Registration number
- 8224811
- Mark type
- Word mark
- Filed
- 13 Jun 2024
- Published for opposition
- 04 Feb 2025
- Registered
- 21 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 21 Apr 2032 (grace period to 21 Oct 2032)
- Attorney of record
- Eric J. Shimanoff
Goods and services
- Class 005 — Pharmaceuticals: Human antibody-based pharmaceutical for treatment and prophylaxis for Ebola Virus Disease
Owner
- Ridgeback Biotherapeutics L.P., Coconut Grove, FL, US
- Ridgeback Biotherapeutics L.P., Coconut Grove, FL, US
- Ridgeback Biotherapeutics L.P., Coconut Grove, FL, US
Prosecution history
- 21 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Mar 2026 — ASSIGNED TO LIE
- 25 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 11 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Sept 2025 — USE AMENDMENT FILED
- 10 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Sept 2025 — TEAS STATEMENT OF USE RECEIVED